Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blue Orca Capital is an activist short-selling investment firm that specializes in forensic research and investigative analysis of publicly traded companies. Founded by Soren Aandahl, the firm identifies businesses with alleged accounting discrepancies, corporate governance failures, or misleading operational claims. Blue Orca publishes detailed research reports to support its short positions, often targeting companies across the healthcare, technology, and consumer sectors. The firm's activities are designed to expose overvalued equities and promote market-based accountability through deep-dive investigations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blue Orca Capital.